Page 41 - IMCJ19s1
P. 41

Palmitoylethanolamide (PEA)
               PEA is a naturally occurring anti-inflammatory palmitic   generally  600  mg  three  times  daily  for  up  to  three
            acid  derivative  that  interfaces  with  the  endocannabinoid   weeks. There are multiple mechanisms of action associated
            system. There was a significantly favorable outcome in five   with PEA, from inhibition of TNF-alpha and NF-kB to mast
            of six double blind placebo-controlled trials looking at acute   cell stabilization. In influenza, it is thought that PEA works
            respiratory  disease  due  to  influenza. 115   Dosing  was   by attenuating the potentially fatal cytokine storm.

            Intervention                   Palmitoylethanolamide (PEA)
            Suggested dose                 300 mg po bid to prevent infection, 600 mg po tid x two weeks to treat
                                           infection
            Mechanism(s) of action against   Favorably modulate cellular defense and repair mechanisms
            non-COVID-19 viruses 115       Favorably modulate viral-induced pathological cellular processes
            Outcomes data supporting their   No data available
            mitigating effects on illness from
            other viral strains
            Strength of evidence           PEA = conditional (treatment)
                                           PEA = strong (prevention)
            Risk of harm 116-119           Mimimal


            Vitamin C
               Vitamin  C  contributes  to  immune  defense  by   species, and ultimately microbial killing. Supplementation
            supporting  various  cellular  functions  of  both  the  innate   with vitamin C appears to be able to both prevent and treat
            and adaptive immune system. Vitamin C accumulates in   respiratory and systemic infections.  Vitamin C has been
                                                                                         120
            phagocytic  cells,  such  as  neutrophils,  and  can  enhance   used in hospital ICUs to treat COVID-19.
            chemotaxis,  phagocytosis,  generation  of  reactive  oxygen

            Intervention                   Vitamin C
            Suggested dose                 1–3 grams po qd
            Mechanism(s) of action against   Favorably modulate cellular defense and repair mechanisms
            non-COVID-19 viruses 120       Favorably modulate viral-induced pathological cellular processes
            Outcomes data supporting their   No data available
            mitigating effects on illness from
            other viral strains
            Strength of evidence           Strong
            Risk of harm 121               Mimimal

            Zinc
               Zinc  contributes  to  immune  defense  by  supporting   accurately  diagnosis  with  laboratory  measures.
            various cellular functions of both the innate and adaptive   Supplementation with zinc is supported by evidence that it
            immune system. There is also evidence that it suppresses   both prevents viral infections and reduces their severity
            viral  attachment  and  replication.    Zinc  deficiency  is   and duration. Moreover, it has been shown to reduce the
            common, especially in those populations most at risk for   risk  of  lower  respiratory  infection,  which  may  be  of
            severe  SARS-CoV-2  infections,  and  is  challenging  to   particular significance in the context of COVID-19.
            Intervention                   Zinc
            Suggested Dose                 30–60 mg daily in divided doses
                                           Zinc acetate, citrate, picolinate or glycinate orally. Zinc gluconate as lozenge.
            Mechanism(s) of action against non- Favorably modulate innate and adaptive immune system
            COVID-19 viruses 120-127       Favorably modulate viral-induced pathological cellular processes, attachment and
                                           replication
            Outcomes data supporting their   Prevention, reduced severity of symptoms, reduced duration of illness,
            mitigating effects on illness from   prevention of lower respiratory tract infection
            other viral strains
            Strength of evidence           Strong
            Risk of harm 128               Mimimal




            Evans—Virus-Specific Nutraceutical and Botanical Agents  Integrative Medicine • Vol. 19, No. S1 • Epub Ahead of Print  39
   36   37   38   39   40   41   42   43   44   45   46